March 2026
1. MCHUGH MP, Goldstein E, Cairns F, Calder C, et al
   Laboratory evaluation of the Allplex NG & DR assay for detection of Neisseria gonorrhoeae and associated azithromycin and ciprofloxacin resistance markers.
   Sex Transm Infect. 2026 Mar 5:sextrans-2025-056494.
   

   >> Share

   
   February 2026
2. GRANT A, Keegan S, Kulasegaram R
   Role of long-acting injectables in perinatally acquired HIV, with persistent viraemia and non-nucleoside reverse transcriptase inhibitor resistance.
   Sex Transm Infect. 2026;102:107-108.
   

   >> Share

   
   
3. TSOUMANIS A, Vanbaelen T, Van Dijck C, Kenyon C, et al
   Screening for gonorrhoea and chlamydia: identifying key target populations and intensity-a modelling study of MSM in Belgium.
   Sex Transm Infect. 2026;102:66-73.
   

   >> Share

   
   January 2026
4. VANBAELEN T, Huis In 't Veld D, Visser BJ, De Baetselier I, et al
   Combination therapy for multidrug-resistant Mycoplasma genitalium infections: a case series.
   Sex Transm Infect. 2026;102:43-46.
   

   >> Share

   
   
5. COLE MJ, Vickers A, Sun S, Day MJ, et al
   What are we missing? Data from the Gonorrhoea Undetected Resistance Laboratory Study (GURLS).
   Sex Transm Infect. 2026;102:32-35.
   

   >> Share

   
   November 2025
6. MCHUGH MP, Aburajab K, Maxwell A, Anderson J, et al
   Investigation of ceftriaxone-resistant Neisseria gonorrhoeae detected in Scotland, 2018-2024.
   Sex Transm Infect. 2025;101:534-537.
   

   >> Share

   
   October 2025
7. QI Y, Xie Q, Lin J, Zhang R, et al
   Exploring alternative therapeutic options for multidrug-resistant N. Gonorrhoeae: the potential of 7,8-dihydroxyflavone.
   Sex Transm Infect. 2025;101:483-486.
   

   >> Share

   
   May 2025
8. PASSARELLI VC, Goldemberg F, Lazari CDS, Carnevale GG, et al
   Antimicrobial resistance and treatment failures in symptomatic and asymptomatic Mycoplasma genitalium infections in Sao Paulo, Brazil: first evidence from a cross-sectional study of sexual health clinic attendees.
   Sex Transm Infect. 2025 May 16:sextrans-2025-056586.
   

   >> Share

   
   March 2025
9. SIATRAVANI E, Panopoulou AD, Polemis M, Chryssou SE, et al
   Epidemiological characteristics and antibiotic susceptibility of Neisseria gonorrhoeae isolates from Greece during 2009-2023.
   Sex Transm Infect. 2025 Mar 27:sextrans-2024-056279.
   

   >> Share

   
   
10. MIARI VF, Blakiston MR, Solanki P, Gundogdu O, et al
    Characterisation of Neisseria gonorrhoeae strain differences in patients with multisite infection.
    Sex Transm Infect. 2025;101:88-93.
    

    >> Share

    
    
11. LARA I, Hernandez-Ruiz V, Fernandez-Huerta M, Rodriguez-Grande J, et al
    Mycoplasma genitalium and antimicrobial resistance among the general female and male population in northern Spain.
    Sex Transm Infect. 2025 Mar 12:sextrans-2024-056374.
    

    >> Share

    
    January 2025
12. RATNER JC, Wilson J, Roberts K, Armitage C, et al
    Increasing rate of non-Candida albicans yeasts and fluconazole resistance in yeast isolates from women with recurrent vulvovaginal candidiasis in Leeds, United Kingdom.
    Sex Transm Infect. 2025;101:21-26.
    

    >> Share

    
    October 2024
13. ZACE D, Rindi LV, Compagno M, Colagrossi L, et al
    Managing low-level HIV viraemia in antiretroviral therapy: a systematic review and meta-analysis.
    Sex Transm Infect. 2024;100:460-468.
    

    >> Share

    
    
14. DAY MJ, Boampong D, Pitt R, Bari A, et al
    Molecular detection of ceftriaxone resistance in Neisseria gonorrhoeae clinical specimens: a tool for public health control.
    Sex Transm Infect. 2024;100:454-456.
    

    >> Share

    
    August 2024
15. VANBAELEN T, Rotsaert A, De Baetselier I, Platteau T, et al
    Doxycycline post-exposure prophylaxis among men who have sex with men and transgender women in Belgium: awareness, use and antimicrobial resistance concerns in a cross-sectional online survey.
    Sex Transm Infect. 2024 Aug 29:sextrans-2024-056261.
    

    >> Share

    
    
16. BJARTLING C, Kertes R, Kristiansen S, Johnsson A, et al
    Prevalence of Mycoplasma genitalium and macrolide resistance in rectal and urine samples among men who have sex with men in Sweden.
    Sex Transm Infect. 2024 Aug 1:sextrans-2023-056044.
    

    >> Share

    
    
17. JOHNSON K, Buluwela E, McDonald G, Golden J, et al
    Mycoplasma genitalium treatment outcomes among a cohort failing macrolide resistance-guided treatment across three London sexual health clinics.
    Sex Transm Infect. 2024 Aug 1:sextrans-2023-056093.
    

    >> Share

    
    July 2024
18. IM YR, Mohammed KS, Martyn E, Lumley S, et al
    Social, clinical and biological barriers to hepatitis B virus suppression with nucleos/tide analogue therapy: who is at risk and what should we do about it?
    Sex Transm Infect. 2024;100:259-263.
    

    >> Share

    
    
19. LUMLEY S, Barlow M, Said K, Martyn E, et al
    Multiple risk factors for persistent HBV viraemia in an adult receiving nucleos/tide analogue therapy.
    Sex Transm Infect. 2024;100:329-331.
    

    >> Share

    
    May 2024
20. GOLDSTEIN E, Moss E, Bennett-Slater S, Ferguson L, et al
    Impact of molecular ciprofloxacin resistance testing in management of gonorrhoea in a large urban clinic.
    Sex Transm Infect. 2024 May 3:sextrans-2023-056099.
    

    >> Share

    
    April 2024
21. TEKER B, Schim van der Loeff M, Hoornenborg E, Boyd A, et al
    Minimum inhibitory concentrations of Neisseria gonorrhoeae strains in clients of the Amsterdam sexual health clinic with a Dutch versus an international sexual network.
    Sex Transm Infect. 2024;100:173-180.
    

    >> Share

    
    September 2023
22. DRUD ST, Anagrius C, Lore B, Elfving K, et al
    Changes in prevalence of Mycoplasma genitalium macrolide and fluoroquinolone resistance: notes from a 13-year retrospective survey in Dalarna County, Sweden.
    Sex Transm Infect. 2023 Sep 13:sextrans-2023-055900.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share